A Bridging Study to Assess the Safety of the Vaccine Adacel in a Clinical Trial.
Phase of Trial: Phase III
Latest Information Update: 27 May 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Registrational
- Sponsors Sanofi
- 10 Apr 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.
- 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2010 New trial record